aminolevulinic acid has been researched along with Graft-Versus-Host Disease in 5 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Scleroderma or systemic sclerosis (SSc) is a clinically heterogeneous rheumatological autoimmune disease affecting the skin, internal organs and blood vessels." | 5.48 | Combination of 5-aminolevulinic acid and iron prevents skin fibrosis in murine sclerodermatous graft-versus-host disease. ( Fujino, M; Ito, H; Li, XK; Liu, C; Nakajima, M; Takahashi, K; Tanaka, T; Wang, J; Yang, X; Zhu, P; Zhuang, J; Zou, H, 2018) |
| "This study investigated the hypothesis that 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) might alleviate acute graft-versus-host disease (GVHD) following allogenic bone marrow transplantation (allo-BMT) in mice." | 3.73 | [ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation]. ( Pan, KL; Ran, HH; Wang, YF; Zhang, R, 2006) |
| "Scleroderma or systemic sclerosis (SSc) is a clinically heterogeneous rheumatological autoimmune disease affecting the skin, internal organs and blood vessels." | 1.48 | Combination of 5-aminolevulinic acid and iron prevents skin fibrosis in murine sclerodermatous graft-versus-host disease. ( Fujino, M; Ito, H; Li, XK; Liu, C; Nakajima, M; Takahashi, K; Tanaka, T; Wang, J; Yang, X; Zhu, P; Zhuang, J; Zou, H, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holien, T | 1 |
| Gederaas, OA | 1 |
| Darvekar, SR | 1 |
| Christensen, E | 1 |
| Peng, Q | 1 |
| Liu, C | 3 |
| Yang, X | 1 |
| Zhu, P | 2 |
| Fujino, M | 1 |
| Ito, H | 3 |
| Takahashi, K | 3 |
| Nakajima, M | 3 |
| Tanaka, T | 3 |
| Wang, J | 1 |
| Zhuang, J | 1 |
| Zou, H | 1 |
| Li, XK | 3 |
| Ran, HH | 1 |
| Pan, KL | 1 |
| Zhang, R | 1 |
| Wang, YF | 1 |
| Wang, Z | 2 |
| Ma, K | 1 |
| Hu, X | 2 |
| Que, W | 1 |
| Ren, K | 1 |
| Guo, WZ | 1 |
| Yi, SQ | 1 |
5 other studies available for aminolevulinic acid and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
Topics: Aminolevulinic Acid; Cell Culture Techniques; Graft vs Host Disease; Humans; Lymphoma, T-Cell, Cutan | 2018 |
Combination of 5-aminolevulinic acid and iron prevents skin fibrosis in murine sclerodermatous graft-versus-host disease.
Topics: Aminolevulinic Acid; Animals; Collagen Type I; Cytokines; Disease Models, Animal; Drug Therapy, Comb | 2018 |
[ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation].
Topics: Aminolevulinic Acid; Animals; Bone Marrow Transplantation; Female; Graft vs Host Disease; Leukocyte | 2006 |
5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.
Topics: Alanine Transaminase; Aminolevulinic Acid; Animals; Aspartate Aminotransferases; Citric Acid; Cytoki | 2021 |
5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model.
Topics: Aminolevulinic Acid; Animals; B-Lymphocytes; Blood Urea Nitrogen; Body Weight; CD8-Positive T-Lympho | 2021 |